Rendering

Component: (Network and Table)
Network
2315301 - Disclosure - Shareholders' Equity (Tables)
(http://www.amsurg.com/role/ShareholdersEquityTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000895930 (http://www.sec.gov/CIK)
Equity [Abstract]Period [Axis]
2015-01-01 - 2015-12-31
Equity [Abstract]
 
Share-Based Activity
Other information pertaining to share-based activity for the years ended December 31, 2015, 2014 and 2013 was as follows (in thousands):
 
2015
 
2014
 
2013
Share-based compensation expense
$
15,009

 
$
10,104

 
$
8,321

Fair value of shares vested
13,220

 
15,126

 
11,742

Cash received from option exercises
2,584

 
2,630

 
33,349

Tax benefit from option exercises
4,001

 
3,177

 
7,247

  
Schedule Of Changes In Non-Vested Restricted Shares
A summary of the status of and changes for non-vested restricted shares for the three years ended December 31, 2015, is as follows:
 
 
 
Weighted
 
Number
 
Average
 
of Shares
 
Grant Price
Non-vested shares at January 1, 2013
828,686

 
$
22.50

Shares granted
291,863

 
31.66

Shares vested
(360,337
)
 
21.55

Shares forfeited
(16,343
)
 
23.11

Non-vested shares at December 31, 2013
743,869

 
$
26.54

Shares granted
272,780

 
43.12

Shares vested
(336,160
)
 
25.69

Shares forfeited
(12,380
)
 
38.94

Non-vested shares at December 31, 2014
668,109

 
$
33.51

Shares granted
313,498

 
56.19

Shares vested
(233,831
)
 
28.19

Shares forfeited
(13,675
)
 
42.15

Non-vested shares at December 31, 2015
734,101

 
$
44.73

  
Schedule Of Stock Option Activity
A summary of stock option activity for the three years ended December 31, 2015 is summarized as follows:
 
 
 
 
 
Weighted
 
 
 
Weighted
 
Average
 
 
 
Average
 
Remaining
 
Number
 
Exercise
 
Contractual
 
of Shares
 
Price
 
Term (in years)
Outstanding at January 1, 2013
1,662,830

 
$
23.82

 
2.9
Options exercised with total intrinsic value of $33.3 million
(1,392,366
)
 
23.95

 
 
Outstanding at December 31, 2013
270,464

 
$
23.16

 
2.5
Options exercised with total intrinsic value of $2.6 million
(111,743
)
 
23.53

 
 
Outstanding at December 31, 2014
158,721

 
$
22.89

 
1.7
Options exercised with total intrinsic value of $4.9 million
(113,220
)
 
22.81

 
 
Options terminated
(11,750
)
 
23.42

 
 
Outstanding, Vested and Exercisable at December 31, 2015 with an aggregate intrinsic value of $1.8 million
33,751

 
$
22.98

 
1.1
  
Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share

The following is a reconciliation of the numerator and denominators of basic and diluted earnings per share (in thousands, except per share amounts):
 
Earnings
 
Shares
 
Per Share
 
(Numerator)
 
(Denominator)
 
Amount
For the year ended December 31, 2015:
 

 
 
 
 

Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (basic)
$
154,892

 
48,058

 
$
3.22

Preferred stock dividends
9,056

 
—

 
 
Effect of dilutive securities, options and non-vested shares
—

 
3,554

 
 

Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (diluted)
$
163,948

 
51,612

 
$
3.18

 
 
 
 
 
 
For the year ended December 31, 2014:
 
 
 

 
 

Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (basic)
$
50,777

 
39,311

 
$
1.29

Effect of dilutive securities, options and non-vested shares
—

 
314

 
 
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (diluted)
$
50,777

 
39,625

 
$
1.28

 
 
 
 
 
 
For the year ended December 31, 2013:
 
 
 

 
 

Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (basic)
$
71,009

 
31,338

 
$
2.27

Effect of dilutive securities, options and non-vested shares
—

 
616

 
 
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (diluted)
$
71,009

 
31,954

 
$
2.22